Grupo farmacéutico · Japón
Takeda
Un grupo de 73 empresas con 1198 medicamentos en 12 países.
Estructura del grupo
73 empresas en 23 países
Cargando la página…
Cargando la página…
Grupo farmacéutico · Japón
Un grupo de 73 empresas con 1198 medicamentos en 12 países.
73 empresas en 23 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 1198
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| ACTOPLUS MET500MG; 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 850MG; 15MG BASE · Tablet | Metformin, Pioglitazone | Estados Unidos | Comercializado | 2005 |
| ACTOPLUS MET XR1gm; 15mg base | 1gm; 30mg base · Tablet, extended release | Metformin, Pioglitazone | Estados Unidos | No comercializado | 2009 |
| ACTOS15mg base | 30mg base | 45mg base · Tablet | Pioglitazone | Estados Unidos | Comercializado | 1999 |
| ACTOS 30 mg COMPRIMIDOS30 mg · Comprimido | Pioglitazone | España | Comercializado | 2020 |
| ACTOS 30 MG COMPRIMIDOS30 mg · Comprimido | Pioglitazone | España | Comercializado | 2020 |
| Adcetris | Brentuximab vedotin | UE (EMA) | Autorizado | 2012 |
| ADCETRIS | Brentuximab vedotin | Brasil | Autorizado | 2026 |
| ADCETRISConcentrato per soluzione per infusione | Brentuximab vedotin | Italia | Autorizado | |
| Adcetris 50 mg, poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie | Brentuximab vedotin | Países Bajos | Autorizado | 2012 |
| ADCETRIS 50 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION50 mg · Polvo para concentrado para solución para perfusión | Brentuximab vedotin | España | Autorizado | 2021 |
| ADCETRIS 50 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION50 mg · Polvo para concentrado para solución para perfusión | Brentuximab vedotin | España | Comercializado | 2012 |
| Adcetris®50mg · prašak za koncentrat za rastvor za infuziju | Brentuximab vedotin | Serbia | Autorizado | 2023 |
| ADCETRIS® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL50mg/vial · Injection, powder, for solution | Brentuximab vedotin | Singapur | Autorizado | 2014 |
| ADDERALL XR10 mg · Capsule (Extended-Release) | Amfetamine | Canadá | Comercializado | 2004 |
| ADDERALL XR5 mg · Capsule (Extended-Release) | Amfetamine | Canadá | Comercializado | 2004 |
| ADDERALL XR20 mg · Capsule (Extended-Release) | Amfetamine | Canadá | Comercializado | 2004 |
| ADDERALL XR15 mg · Capsule (Extended-Release) | Amfetamine | Canadá | Comercializado | 2004 |
| ADDERALL XR25 mg · Capsule (Extended-Release) | Amfetamine | Canadá | Comercializado | 2004 |
| ADDERALL XR30 mg · Capsule (Extended-Release) | Amfetamine | Canadá | Comercializado | 2004 |
| ADDERALL XR 102.5mg; 2.5mg; 2.5mg; 2.5mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | Estados Unidos | Comercializado | 2001 |
| ADDERALL XR 153.75mg; 3.75mg; 3.75mg; 3.75mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | Estados Unidos | Comercializado | 2001 |
| ADDERALL XR 205mg; 5mg; 5mg; 5mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | Estados Unidos | Comercializado | 2001 |
| ADDERALL XR 256.25mg; 6.25mg; 6.25mg; 6.25mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | Estados Unidos | Comercializado | 2001 |
| ADDERALL XR 307.5mg; 7.5mg; 7.5mg; 7.5mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | Estados Unidos | Comercializado | 2001 |
| ADDERALL XR 51.25mg; 1.25mg; 1.25mg; 1.25mg · Capsule, extended release | Amphetamine aspartate, Amfetamine, Dextroamphetamine saccharate, Dexamfetamine | Estados Unidos | Comercializado | 2001 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| España | 210 | 178 | 32 | EmpresasTodos los medicamentos |
| Brasil | 195 | 56 | 139 | EmpresasTodos los medicamentos |
| Canadá | 159 | 119 | 40 | EmpresasTodos los medicamentos |
| Estados Unidos | 147 | 146 | 1 | EmpresasTodos los medicamentos |
| Países Bajos | 114 | 114 | 0 | EmpresasTodos los medicamentos |
| Arabia Saudí | 110 | 110 | 0 | EmpresasTodos los medicamentos |
| Italia | 53 | 53 | 0 | EmpresasTodos los medicamentos |
| Serbia | 53 | 53 | 0 | EmpresasTodos los medicamentos |
| Singapur | 50 | 50 | 0 | EmpresasTodos los medicamentos |
| Rumanía | 49 | 0 | 49 | EmpresasTodos los medicamentos |
| Unión Europea (EMA) | 48 | 36 | 12 | EmpresasTodos los medicamentos |
| Croacia | 10 | 10 | 0 | EmpresasTodos los medicamentos |
También en los registros de Francia, Reino Unido
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licencia: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licencia: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licencia: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licencia: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Estonian Centre of Registers and Information Systems (RIK), e-Business Register open general data; exact registry code, field locator, source Last-Modified and retrieval date. CC BY 4.0 International; selected corporate field export/normalization by Prognia.
Licencia: Creative Commons Attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licencia: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licencia: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licencia: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licencia: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licencia: Norwegian Licence for Open Government Data
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licencia: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licencia: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licencia: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licencia: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Takeda en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaGrupos farmacéuticos conocidos, cada uno con todas sus empresas.
Ordenados por su número de medicamentos.